Browse Pet Safety Reports
16,709 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 16,709 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 16,709 FDA veterinary adverse event reports for Human.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Nov 9, 2020 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Recovered/Normal |
| Nov 9, 2020 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Drug dispensing error | Recovered/Normal |
| Nov 9, 2020 | Human | Unknown | Mirtazapine | Feeling anxious; Disoriented state; Medication error | Recovered/Normal |
| Nov 6, 2020 | Human | Unknown | Pergolide Mesylate | Shaking; Vomiting | Recovered/Normal |
| Nov 3, 2020 | Human | Unknown | Sevoflurane | Dizziness | Recovered/Normal |
| Nov 3, 2020 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Containers, Leaking | Recovered/Normal |
| Nov 3, 2020 | Human | Unknown | Fluralaner/Moxidectin Spot-On | Application site skin change NOS | Recovered/Normal |
| Nov 3, 2020 | Human | Unknown | Fluralaner/Moxidectin Spot-On | Application site skin change NOS; Headache; Bad taste | Recovered/Normal |
| Nov 3, 2020 | Human | Unknown | Fluralaner Spot-On Solution | Application site tingling; Drug administration error | Recovered/Normal |
| Nov 2, 2020 | Human | Unknown | Selamectin;Sarolaner | Nasal irritation | Outcome Unknown |
| Nov 1, 2020 | Human | Unknown | Afoxolaner | Localised itching; Local swelling (not application site); Skin warmth | Outcome Unknown |
| Nov 1, 2020 | Human | Unknown | Trilostane | Miscarriage; Birth defect; Drug administration error | Recovered with Sequela |
| Nov 1, 2020 | Human | Unknown | Isoflurane | Bradycardia; Feelings of weakness; Dizziness; Heart block 3rd degree | Ongoing |
| Oct 28, 2020 | Human | Unknown | Fluralaner Spot-On Solution | Localised rash | Ongoing |
| Oct 27, 2020 | Human | Unknown | Fluralaner Spot-On Solution | Localised rash | Ongoing |
| Oct 27, 2020 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Ongoing |
| Oct 27, 2020 | Human | Unknown | Fluralaner Spot-On Solution | Localised rash | Ongoing |
| Oct 25, 2020 | Human | Unknown | Imidacloprid | Fatigue; Accidental exposure | Recovered/Normal |
| Oct 25, 2020 | Human | Unknown | Nitenpyram | Vomiting | Recovered/Normal |
| Oct 23, 2020 | Human | Unknown | Flunixin Meglumine Injectable | Eye irritation; Vision blurred | Ongoing |
| Oct 23, 2020 | Human | Unknown | Flunixin Meglumine Injectable | Eye irritation; Eye pain; Vision blurred | Outcome Unknown |
| Oct 22, 2020 | Human | Unknown | Ivermectin | Puncture wound; Injection site bleeding | Recovered/Normal |
| Oct 21, 2020 | Human | Unknown | Ceftiofur Crystalline Free Acid | Injection site pain; Injection site stiffness; Injection site swelling; Punct... | Outcome Unknown |
| Oct 21, 2020 | Human | Unknown | Eprinomectin; Praziquantel | Nasal irritation; Sinus headache; Bad taste | Outcome Unknown |
| Oct 21, 2020 | Human | Unknown | Selamectin | Itchy skin | Recovered/Normal |
| Oct 20, 2020 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Recovered/Normal |
| Oct 20, 2020 | Human | Unknown | Tilmicosin | Injection site reddening; Increased heart rate; Numbness | Recovered/Normal |
| Oct 19, 2020 | Human | Unknown | Ivermectin | Eye irritation; Dermatosis NOS; Burning sensation of eye | Recovered/Normal |
| Oct 19, 2020 | Human | Unknown | Tilmicosin | Injection site bleeding; Localised pain NOS (see other 'SOCs' for specific pa... | Ongoing |
| Oct 18, 2020 | Human | Unknown | Tulathromycin | Localised rash; Numbness | Ongoing |
| Oct 17, 2020 | Human | Unknown | Tulathromycin | Injection site irritation | Outcome Unknown |
| Oct 17, 2020 | Human | Unknown | Pirlimycin Hydrochloride | Eye irritation | Outcome Unknown |
| Oct 17, 2020 | Human | Unknown | Selamectin | Hives (see also 'Skin'); Anaphylactic-type reaction | Ongoing |
| Oct 16, 2020 | Human | Unknown | Insulin Injectable Vial | Injection site bleeding; Accidental exposure; Drug administration error | Outcome Unknown |
| Oct 16, 2020 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Drug administration error | Recovered/Normal |
| Oct 16, 2020 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Drug administration error | Outcome Unknown |
| Oct 15, 2020 | Human | Unknown | Florfenicol, Terbinafine, Betamethaso... | Application site reddening; Application site irritation; Application site pai... | Outcome Unknown |
| Oct 13, 2020 | Human | Unknown | Selamectin | Hives (see also 'Skin'); Anaphylactic-type reaction | Ongoing |
| Oct 13, 2020 | Human | Unknown | Flunixin Meglumine Injectable | Eye disorder NOS (for photophobia see 'neurological') | Ongoing |
| Oct 12, 2020 | Human | Unknown | Fluralaner Spot-On Solution | Throat irritation; Abdominal pain | Ongoing |
| Oct 11, 2020 | Human | Unknown | Afoxolaner | Hives (see also 'Skin'); Stinging skin; Rash; Environmental adverse event; An... | Outcome Unknown |
| Oct 10, 2020 | Human | Unknown | Tulathromycin | Puncture wound; Injection site bleeding; Injection site pain | Outcome Unknown |
| Oct 10, 2020 | Human | Unknown | Tulathromycin | Application site reddening; Skin lesion NOS; Skin inflammation NOS | Outcome Unknown |
| Oct 10, 2020 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Outcome Unknown |
| Oct 9, 2020 | Human | Unknown | Selamectin | Rash | Outcome Unknown |
| Oct 8, 2020 | Human | Unknown | Mirtazapine | Hypertension; Medication error | Outcome Unknown |
| Oct 8, 2020 | Human | Unknown | Pregnyl/Gestyl 200/400 | Injection site bleeding | Outcome Unknown |
| Oct 7, 2020 | Human | Unknown | Selamectin | Hives (see also 'Skin'); Pruritus; Localised oedema (not application site); A... | Ongoing |
| Oct 5, 2020 | Human | Unknown | Maropitant Citrate | Puncture wound; Injection site numbness | Recovered/Normal |
| Oct 5, 2020 | Human | Unknown | Neomycin Sulfate; Thiabendazole; Dexa... | Eye irritation | Outcome Unknown |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.